Patent · US Active

Chimeric newcastle disease viruses and uses thereof

US10035984B2 · kind B2 · utility

1Cited by

22References

18Claims

0Family size

Assignees

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · US
Memorial Sloan Kettering Cancer Center · US

Inventors

Peter Palese · Leonia, US
Adolfo Garcia-Sastre · New York, US
Dmitriy Zamarin · New York, US
Yuman Fong · Duarte, US

Key dates

Filing date	Nov 16, 2015
Grant date	Jul 31, 2018
Priority date	—
Expiry date	Feb 12, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/18171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are chimeric Newcastle disease viruses engineered to express a heterologous interferon antagonist and compositions comprising such viruses. The chimeric Newcastle disease viruses and compositions are useful in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.